Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
HSM
Helius Medical Technologies
C$0.00
C$14.26
C$40.00
C$42.54MN/A3,578 shs930 shs
Safeguard Scientifics, Inc. stock logo
SFE
Safeguard Scientifics
$0.37
$0.40
$3.25
$7.54M0.9587,936 shs899,300 shs
Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
HSM
Helius Medical Technologies
0.00%0.00%0.00%0.00%0.00%
Safeguard Scientifics, Inc. stock logo
SFE
Safeguard Scientifics
0.00%0.00%0.00%0.00%0.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
HSM
Helius Medical Technologies
N/AN/AN/AN/AN/AN/AN/AN/A
Safeguard Scientifics, Inc. stock logo
SFE
Safeguard Scientifics
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
HSM
Helius Medical Technologies
0.00
N/AN/AN/A
Safeguard Scientifics, Inc. stock logo
SFE
Safeguard Scientifics
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
HSM
Helius Medical Technologies
C$477K0.00N/A5.71C$3.61 per share0.00
Safeguard Scientifics, Inc. stock logo
SFE
Safeguard Scientifics
N/AN/AN/AN/A$2.12 per shareN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
HSM
Helius Medical Technologies
N/A-C$11.02N/AN/AN/AN/AN/AN/AN/A
Safeguard Scientifics, Inc. stock logo
SFE
Safeguard Scientifics
-$14.26M-$0.64N/AN/AN/AN/A-33.01%-30.50%N/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
HSM
Helius Medical Technologies
N/AN/AN/AN/AN/A
Safeguard Scientifics, Inc. stock logo
SFE
Safeguard Scientifics
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
HSM
Helius Medical Technologies
0.74
4.20
3.58
Safeguard Scientifics, Inc. stock logo
SFE
Safeguard Scientifics
N/A
10.41
10.41

Institutional Ownership

CompanyInstitutional Ownership
HSM
Helius Medical Technologies
N/A
Safeguard Scientifics, Inc. stock logo
SFE
Safeguard Scientifics
44.14%

Insider Ownership

CompanyInsider Ownership
HSM
Helius Medical Technologies
N/A
Safeguard Scientifics, Inc. stock logo
SFE
Safeguard Scientifics
9.70%
CompanyEmployeesShares OutstandingFree FloatOptionable
HSM
Helius Medical Technologies
192.32 millionN/ANot Optionable
Safeguard Scientifics, Inc. stock logo
SFE
Safeguard Scientifics
2,01616.58 million14.97 millionOptionable

Recent News About These Companies

Safeguard Scientifics: Q1 Earnings Snapshot
Feds renew scientific integrity plans
Safeguard Scientifics: Q4 Earnings Snapshot
SFE Apr 2024 2.150 put
OTC Markets Group Welcomes Safeguard Scientifics, Inc. to OTCQX

Media Sentiment Over Time

Top Headlines

View All Headlines

Helius Medical Technologies TSE:HSM

Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator (PoNS), is a non-implantable investigational medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company is headquartered in Newtown, Pennsylvania.

Safeguard Scientifics stock logo

Safeguard Scientifics NYSE:SFE

Safeguard Scientifics, Inc. no longer investing. It is a private equity and venture capital firm specializing in expansion financings, growth capital, management buyouts, recapitalizations, industry consolidations, corporate spinouts, growth stage, and early stage financings. It initially invests in a Series A-C round and opportunistically in a seed round. The firm prefers to make investments in companies engaged in the technology, financial services, and healthcare sector. Within the technology sector, it invests in software as a service, adtech / digital media, Internet of Everything, enhanced security, predictive analytics, machine learning, artificial intelligence, enterprise software, technology enabled services, internet/new media, financial technology, cloud, mobile, social, big data, in memory, and selected business services with capital requirements of up to $25 million. Within healthcare sector, the firm invests in molecular and point-of-care diagnostics, medical devices, regenerative medicine, medical technology, digital health, healthcare technology, specialty pharmaceuticals, and selected healthcare services. It invests throughout the United States with a focus on Mid-Atlantic region, and Southeastern Canada. The firm primarily invests between $5 million and $25 million in growth equity financing and between $5 million and $10 million in early-stage financing. It typically invests in the capital structures including owner financed and bootstrapped companies, corporate division or business unit, and venture capital-backed seeking a growth partner. The firm prefers to be the largest shareholder in its portfolio companies, with ownership in the range of 20 percent to 50 percent. However, it may occasionally take a majority or smaller stake in its portfolio companies. It prefers to invest in companies having proprietary technology and intellectual property. The firm prefers to take a Board seat in its portfolio companies. The company was founded in 1953 as Lancaster Corporation and changed its name to Safeguard Scientifics, Inc. in 1981. Safeguard Scientifics, Inc. is based in Radnor, Pennsylvania with additional office in Weston, Massachusetts.